Compounds > temozolomide
Page last updated: 2024-11-04

temozolomide and Erythroderma, Sezary

temozolomide has been researched along with Erythroderma, Sezary in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases."6.76Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. ( Baron, J; Dolan, ME; Foss, F; Guitart, J; Kuzel, TM; Pezen, DS; Querfeld, C; Rademaker, A; Rosen, ST; Yarosh, DB, 2011)
"Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases."2.76Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. ( Baron, J; Dolan, ME; Foss, F; Guitart, J; Kuzel, TM; Pezen, DS; Querfeld, C; Rademaker, A; Rosen, ST; Yarosh, DB, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Querfeld, C1
Rosen, ST1
Guitart, J1
Rademaker, A1
Pezen, DS1
Dolan, ME1
Baron, J1
Yarosh, DB1
Foss, F1
Kuzel, TM1

Trials

1 trial available for temozolomide and Erythroderma, Sezary

ArticleYear
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Sep-01, Volume: 17, Issue:17

    Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylat

2011